Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers from Children’s Hospital of Philadelphia (CHOP) discovered a key process where malarial parasites take up a human blood cell enzyme, which could provide a new approach for antimalarial treatment.